These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6180075)

  • 41. The kidney is the main site of interferon degradation.
    Bino T; Madar Z; Gertler A; Rosenberg H
    J Interferon Res; 1982; 2(2):301-8. PubMed ID: 7119510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagenicity studies of human fibroblast interferon (HuIFN-beta).
    Shimada H; Ebine Y; Kurosawa Y; Arauchi T
    Mutat Res; 1984 Apr; 139(4):183-7. PubMed ID: 6371521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic cross-reaction between the alpha types of human and mouse interferon.
    Kawade Y; Watanabe Y; Yamamoto Y; Fujisawa J; Dalton BJ; Paucker K
    Antiviral Res; 1981 Sep; 1(3):167-78. PubMed ID: 6175276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of human fibroblast interferon on human gliomas transplanted into nude mice.
    Tanaka N; Nagao S; Tohgo A; Sekiguchi F; Kohno M; Ogawa H; Matsui T; Matsutani M
    Gan; 1983 Apr; 74(2):308-16. PubMed ID: 6305754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical effect of human fibroblast interferon (BM532) on malignant brain tumors--with special reference to gliomas].
    Nagai M
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):638-46. PubMed ID: 2671205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Qualitative differences in effects of recombinant alpha-, beta- and gamma-interferons on human peripheral blood leukocytes in vitro.
    Billard C; Ferbus D; Kolb JP; Rosa F; Perrot JY; Merlin G; Janiaud P; Raynaud N; Thang MN; Fellous M
    Ann Inst Pasteur Immunol (1985); 1986; 137C(3):259-72. PubMed ID: 3090926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma levels following intranasal and intravenous administration of human interferon-beta to rabbits.
    Maitani Y; Igawa T; Machida Y; Nagai T
    Drug Des Deliv; 1989 Mar; 4(2):109-19. PubMed ID: 2765103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of human fibroblast interferon on human tumors transplanted into nude mice: sensitivity of malignant melanoma.
    Hashizume S; Nagao S; Tanaka N; Sekiguchi F; Kohno M; Ogawa H; Yoshino Y; Seki K; Ishihara K
    Jpn J Exp Med; 1983 Apr; 53(2):77-85. PubMed ID: 6663804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
    Exley T; Parti S; Barwick S; Meager A
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon.
    Weinmann E; Majer M; Hilfenhaus J
    Infect Immun; 1979 Apr; 24(1):24-31. PubMed ID: 110693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An immunoradiometric assay of serum interferon using a monoclonal antibody.
    Walker JR; Nagington J; Scott GM; Secher DS
    J Gen Virol; 1982 Sep; 62 (Pt 1)():181-5. PubMed ID: 7130951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody.
    Mizuno M; Yoshida J; Sugita K; Inoue I; Seo H; Hayashi Y; Koshizaka T; Yagi K
    Cancer Res; 1990 Dec; 50(24):7826-9. PubMed ID: 2174734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2.
    Neumann-Haefelin D; Sundmacher R; Frey H; Merk W
    Med Microbiol Immunol; 1985; 174(2):81-6. PubMed ID: 3929044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon activity and its characterization in the sera of patients with head and neck cancer.
    Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Furumoto N; Hayashi Y; Takegawa Y
    Cancer; 1984 Oct; 54(7):1239-51. PubMed ID: 6205740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential regulation of interferon synthesis in lymphoblastoid cells.
    Raj NB; Kellum M; Kelley KA; Antrobus S; Pitha PM
    J Interferon Res; 1985; 5(3):493-510. PubMed ID: 2997339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Human lamada-interferon expressed in BHK-21 cell line and its bioactivity].
    Yan YL; Liu Y; Cao WY; Bu XF; Bu ZG; Zheng JX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):950-3. PubMed ID: 18845076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effect of human fibroblast interferon on premalignant lesions arising in oral mucosa. A pilot study.
    Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Nitta T; Azuma M; Hayashi Y
    Int J Oral Surg; 1985 Apr; 14(2):184-94. PubMed ID: 2579919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Function, molecular structure and gene expression of interferons].
    Yoshida I; Azuma M
    Nihon Rinsho; 1992 Aug; 50(8):1845-53. PubMed ID: 1279237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys.
    Schellekens H; van Eerd PM; de Reus A; Weck PK; Stebbing N
    Antiviral Res; 1982 Oct; 2(5):313-8. PubMed ID: 6817709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
    Edy VG; Billiau A; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.